| Literature DB >> 27409661 |
Katharina Peters1, Julia Pipo1, Inga Schweizer1, Regine Hakenbeck1, Dalia Denapaite1.
Abstract
Penicillin-binding proteins (PBPs) are membrane-associated enzymes, which are involved in the last two steps of peptidoglycan biosynthesis, and some of them are key players in cell division. Furthermore, they are targets of β-lactams, the most widely used antibiotics. Nevertheless, very little is known about the expression and regulation of PBP genes. Using transcriptional mapping, we now determined the promoter regions of PBP genes from the laboratory strain Streptococcus pneumoniae R6 and examined the expression profile of these six promoters. The extended -10 region is highly conserved and complies with a σ(A)-type promoter consensus sequence. In contrast, the -35 region is poorly conserved, indicating the possibility for differential PBP regulation. All PBP promoters were constitutively expressed and highly active during the exponential and early stationary growth phase. However, the individual expression of PBP promoters varied approximately fourfold, with pbp1a being the highest and pbp3 the lowest. Furthermore, the deletion of one nucleotide in the spacer region of the PBP3 promoter reduced pbp3 expression ∼10-fold. The addition of cefotaxime above the minimal inhibitory concentration (MIC) did not affect PBP expression in the penicillin-sensitive R6 strain. No evidence for regulation of S. pneumoniae PBP genes was obtained.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27409661 PMCID: PMC5036317 DOI: 10.1089/mdr.2016.0084
Source DB: PubMed Journal: Microb Drug Resist ISSN: 1076-6294 Impact factor: 3.431
Bacterial Strains and Plasmids Used in This Study
| Strains | ||
| R6 | Unencapsulated, nonvirulent descendent of D39 | [ |
| RP200 | R6, | [ |
| RKL44 | R6, | [ |
| 801 | Derivative of R6, containing | [ |
| KP01 | R6, | This study |
| KP02 | R6, | This study |
| KP03 | R6, | This study |
| KP04 | R6, | This study |
| KP05 | R6, | This study |
| KP06 | R6, | This study |
| KP09 | R6, | This study |
| Plasmids | ||
| pPP2 | Integrative promoter probe plasmid ( | [ |
| pPP2vegW | pPP2 derivative, carries P | [ |
| pPP21a | pPP2 derivative, carries P | This study |
| pPP21b | pPP2 derivative, carries P | This study |
| pPP22a | pPP2 derivative, carries P | This study |
| pPP22b | pPP2 derivative, carries P | This study |
| pPP22x | pPP2 derivative, carries P | This study |
| pPP23 | pPP2 derivative, carries P | This study |
| pPP23M | pPP2 derivative, carries P | This study |
Antibiotic resistance marker.
Amp, ampicillin; Tet, tetracycline.
Oligonucleotides Used in This Study
| For 5′-RACE amplification | |
| pbp1a_RACE_1 | AAGCTAATGCTCAGATACTTGATTAGG |
| pbp1a_RACE_2 | ATTCCTTGTTGGGCAAGGAC |
| pbp1b_RACE_1 | CACGAATCACCGCCTTGGGTACTACAC |
| pbp1b_RACE_2 | AAGTGCGCAACAAATCACTC |
| pbp2a_RACE_1 | GGTAATGGTAGAGCCACCACCTGAACG |
| pbp2a_RACE_2 | CGGCCATAGTTAATCCCGTC |
| pbp2x_RACE_1 | TTCAGCCGGCGATTTCCGATTTTTGG |
| pbp2x_RACE_2 | CTCACGCTGGTCCAATTGAG |
| pbp2b_RACE_1 | CTGATGCTCACATAAGTCAGTAACTTT |
| pbp2b_RACE_2 | ACGCGTAAAGGAAACAACCTGCTTTAAC |
| pbp3_RACE_1 | ATTGACAACAGTGGCATCCTGAATTCC |
| pbp3_RACE_2 | TCTCAGCTAGGGCAATAGCG |
| RACE-PCR_5′ | GATATGCGCGAATTCCTG |
| 5′ RACE-adapter[ | GAUAUGCGCGAAUUCCUGUAGAACGAACACUAGAAGAAA |
| For promoter probe cloning[ | |
| pbp1a_ppf | AGAT |
| pbp1a_ppr | GCG |
| pbp1b_ppf | ACAT |
| pbp1b_ppr | GCG |
| pbp2a_ppf | ACAT |
| pbp2a_ppr | GCG |
| pbp2x_ppf | ACAT |
| pbp2x_ppr | GCG |
| pbp3_ppf | ACAT |
| pbp3_ppr | GCG |
| pbp2b_ppf | ACAT |
| pbp2b_ppr | GCG |
RNA oligonucleotide obtained from Biomers GmbH.
SphI and BamHI restriction sites are underlined.
RACE, rapid amplification of cDNA ends.

Organization of genomic regions containing Streptococcus pneumoniae R6 PBP genes. The coding regions and their directions of transcription are indicated by arrows and drawn in scale as indicated by the bar representing the size of 1 kb. PBP genes are shown in red, genes organized in operons with PBP genes are white, and flanking genes are imaged in gray. BOX and RUP elements are depicted in blue. Putative promoters are indicated by small black arrows and putative transcriptional terminators are shown as stem-loop structures. Spr numbers represent S. pneumoniae R6 genes. GI number of the S. pneumoniae R6 chromosome sequence in the NCBI Nucleotide database is GI:15902044; pbp1a (pbpA) identified in the NCBI Gene database (GeneID:934791), pbp1b (GeneID:934893), pbp2a (GeneID:933569), pbp2b (GeneID:933948), pbp2x (pbpX, GeneID:934744), and pbp3 (dacA, GeneID:934315). GI, GenInfo identifier; PBP, penicillin-binding protein.

Determination of transcriptional start sites of PBP genes using 5′-RACE. Electropherograms from the DNA sequencing reactions of the 5′-RACE PCR products are shown. The sequences of the RNA adaptors are shown as gray bars. The nucleotides complementary to the 5′ ends of mRNA are shown and the directions of the transcription are indicated by arrows. The first nucleotide represents the transcription initiation site. RACE, rapid amplification of cDNA ends.

Alignment of putative S. pneumoniae R6 PBP promoters. (A) The alignment shows the conserved sequences located upstream of the six PBP loci. The −35 regions marked in orange; the extended −10 region is shown in green within the gray area. Experimentally determined transcriptional start points are shown in blue. The first translation start codons (ATG) are shown in red. (B) The WebLogo[48,49] representation of the position weight matrices derived from the sequences depicted in (A) is shown.

Activity of the PBP promoters in S. pneumoniae R6 strain during growth in C + Y medium. Growth curves and β-galactosidase activities of one representative experiment are shown. Growth was monitored by nephelometry (N, nephelo units). β-galactosidase activities were determined in 30 min intervals and are given in nmol nitrophenol produced per min and mg of protein.

Growth and pbp2x promoter activity in response to cefotaxime treatment. (A) Growth of S. pneumoniae R6 in BHI medium was followed by nephelometry (N). Cefotaxime was added to the exponentially growing cultures at the concentrations (μg/ml) at the time point as indicated by the arrow. (B) Activity of the pbp2x promoter at different time points after the addition of cefotaxime. 0 indicates the time immediately before the cefotaxime addition. β-galactosidase activities were measured after 30, 90, and 150 min and are given in nmol nitrophenol produced per min and mg of protein. Black bars: control, no cefotaxime; gray bars: 0.04 μg/ml cefotaxime; white bars: 0.4 μg/ml cefotaxime. The results are mean value ± SD of three independent experiments. SD, standard deviation.

Effect of the mutation in the PBP3 promoter of S. pneumoniae 801 on PBP3 expression. (A) Comparison of the pbp3 promoter region between S. pneumoniae R6 and the 801 mutant. The −35 (orange) and extended −10 promoter (green within the gray area) regions are boldfaced. The transcriptional start point is shown in blue and the translation start codon of pbp3 is indicated in red. The deletion of one nucleotide in 801 is highlighted by the red box. (B) β-galactosidase activities expressed from the promoters pbp3R6 (gray) and pbp3R801 (black) in KP06 and KP09 strains. Strains were grown in C + Y medium. β-galactosidase activities were determined at four different time points and are given in nmol nitrophenol produced per min and mg of protein. The results are mean value ± SD of three independent experiments.